"what you expect to discover from learning the CDMO they used."
I am just sticky-beaking and filling in time for something to do while we await the next announcement.
"If CEOs were to step down every time a biotech ran into an issue along their development, there'd be a new boss every month."
I agree with that statement. Dr. Campbell was appointed as a non-executive director in November 2014 and was appointed CEO in April 2015. I thought I would see just what has been achieved in that time and perhaps post a chronological list of events. I am only through to the end of 2018 and the list is already too long for me to put in a post. I would venture to suggest that we would not have PAT-DX1 and PAT-DX3 were it not for Dr. Campbell. Nor would we have a world-wide licence for 3E10 (deoxymab) nor the patents that the company now holds. And all of that in addition to the pre-clinical test results that have been achieved.
As a long term holder I am still very positive PAB and happy with the performance of the CEO.
- Forums
- ASX - By Stock
- Ann: Updated guidance for PAT-DX1 phase 1 clinical study
"what you expect to discover from learning the CDMO they used."I...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $11.67K | 1.667M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1024077 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 1520772 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000000 | 0.007 |
5 | 2883931 | 0.006 |
12 | 4116824 | 0.005 |
9 | 5664000 | 0.004 |
6 | 6065682 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 1396890 | 3 |
0.009 | 955280 | 2 |
0.010 | 126000 | 2 |
0.011 | 80000 | 1 |
0.012 | 292407 | 2 |
Last trade - 14.28pm 13/09/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online